[TRANSLATION NOTE] Based on the Korean filing data, Hansol Chemical is a South Korean chemical manufacturer listed on the Korean stock exchange (ticker: 014680). The company operates through consolidated operations, as evidenced by consolidated financial statements (연결재무제표) in the filings. Specific business segment details and product lines are not disclosed in the financial data provided. With a market capitalization of approximately KRW 3.19 trillion, Hansol Chemical represents a mid-cap position in Korea's chemical sector.
Hansol Chemical shows modest top-line growth but declining profitability trends. Revenue reached KRW 776.4 billion in FY2024 (ending December 31, 2024), representing a marginal 0.6% increase from KRW 771.7 billion in FY2023, but still down 12.3% from the FY2022 peak of KRW 885.5 billion.
Operating profit improved slightly to KRW 128.8 billion in FY2024 from KRW 124.1 billion in FY2023, yielding an operating margin of 16.6%, up from 16.1% year-over-year. However, this remains significantly below the 21.0% margin achieved in FY2022, indicating persistent margin compression. Net income grew 14.9% to KRW 124.9 billion in FY2024 from KRW 108.7 billion in FY2023.
The balance sheet strengthened modestly. Total assets increased 8.4% to KRW 1,465 billion at year-end 2024, driven by a 13.5% rise in non-current assets to KRW 1,117 billion, suggesting ongoing capital investment. Total liabilities decreased 4.0% to KRW 393.2 billion, improving the debt-to-equity ratio to 0.37x from 0.43x. Total equity rose 13.8% to KRW 1,071 billion, with retained earnings growing from KRW 811.3 billion to KRW 908.7 billion.
The financial filings provided do not contain detailed ownership or shareholding information. Foreign ownership percentage, controlling shareholder identity, and stake percentages are not disclosed in the balance sheet and income statement data available. This information would typically be found in separate disclosure sections not included in this dataset.
Revenue stagnation and margin erosion: The company has experienced a 12% revenue decline since FY2022 and a 450 basis point contraction in operating margins (from 21.0% to 16.6%), suggesting intensifying competitive pressure or unfavorable industry dynamics in the chemical sector that may persist.
Capital intensity amid uncertain returns: Non-current assets surged 13.5% in FY2024, indicating significant capital deployment (likely new facilities or equipment), yet revenue growth remains flat at 0.6%, raising questions about return on invested capital and the payback timeline for these investments.
Hansol Chemical presents a balance sheet repair story with improving leverage and growing equity, but faces headwinds from margin compression and stagnant revenues that may challenge its ability to generate attractive returns on recent capital investments.
⚠️ This profile is AI-generated from DART filings. Quantitative data is reliable. Qualitative summaries should be verified against original Korean filings for investment decisions.